Rivaroxaban vs. Warfarin for anticoagulation in patients with atrial fibrillation undergoing ablation and cardioversion

Research output: Contribution to journal › Comment/debate

1 Scopus citations

Cite this

@article{057686f5b24b48b283f815e6897d73bd,

title = "Rivaroxaban vs. Warfarin for anticoagulation in patients with atrial fibrillation undergoing ablation and cardioversion",

author = "Hawks, \{Matthew Kendall\} and Carl Bryce",

year = "2016",

month = oct,

day = "1",

language = "English",

volume = "94",

pages = "546A",

journal = "American Family Physician",

issn = "0002-838X",

publisher = "American Academy of Family Physicians",

number = "7",

}

TY - JOUR

T1 - Rivaroxaban vs. Warfarin for anticoagulation in patients with atrial fibrillation undergoing ablation and cardioversion

AU - Hawks, Matthew Kendall

AU - Bryce, Carl

PY - 2016/10/1

Y1 - 2016/10/1

UR - https://www.scopus.com/pages/publications/84990062800

M3 - Comment/debate

C2 - 27929207

AN - SCOPUS:84990062800

SN - 0002-838X

VL - 94

SP - 546A

JO - American Family Physician

JF - American Family Physician

IS - 7

ER -